. 2017 May 18;8(6):1573–1586. doi: 10.1016/j.stemcr.2017.04.019

Table 2.

Establishment Rate of MSC Cultures from BM-AML According to Cytogenetic/Molecular Risk

Prognostic Groups	Cytogenetics/Molecular	Efficiency of BM-MSC Culture Establishment	Mean Age (years) ± SD	Gender Ratio M/F	Mean Blasts (%)
LR-AML	inv(16)/CBFB-MYH11	3/3 (100%)	44.4 ± 26.8	10/6	57.3 ± 24.8
	t(8;21)/AML1-ETO	1/1 (100%)
	t(15;17)/PML-RARa	2/3 (67%)
	NK (NPM^mut,FLT3^wt)	6/8 (75%)
	t(5;15)/TP53BP1-PDGFRB	1/1 (100%)
IR-AML	NK (NPM^wt, FLT3^wt, cEBPa^wt)	10/11 (91%)	55.2 ± 27.9	8/3	54.4 ± 24.5
HR-AML	CK	7/7 (100%)	59.7 ± 22.9	9/10	66.1 ± 25.9
	NK (NPM^wt,FLT3^mut)	4/5 (83%)
	MLL-r (11q23)	5/6 (83%)
	NK/NPM1^mut, IDH1^mut	1/1 (100%)
HD		10/10 (100%)	40 ± 8	6/4	0

NK, normal karyotype; CK, complex karyotype; MLL-r, MLL rearranged; MUT, mutated; HR, high risk; IR, intermediate risk; LR, low risk; HD, healthy donor.